Wall Street Zen upgraded shares of KORU Medical Systems (NASDAQ:KRMD – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.
A number of other equities analysts have also commented on the company. Weiss Ratings raised KORU Medical Systems from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, September 14th. Craig Hallum reiterated a “buy” rating and set a $6.00 price objective on shares of KORU Medical Systems in a research note on Thursday, August 6th. Four investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, KORU Medical Systems presently has a consensus rating of “Moderate Buy” and a consensus target price of $7.00.
Get Our Latest Analysis on KORU Medical Systems
KORU Medical Systems Stock Down 4.7%
KORU Medical Systems (NASDAQ:KRMD – Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.02) by $0.03. KORU Medical Systems had a negative net margin of 4.03% and a negative return on equity of 10.63%. The company had revenue of $12.05 million during the quarter, compared to the consensus estimate of $11.62 million. Equities analysts expect that KORU Medical Systems will post -0.02 EPS for the current year.
Insider Buying and Selling at KORU Medical Systems
In other KORU Medical Systems news, insider Adam Kalbermatten acquired 32,000 shares of the stock in a transaction that occurred on Tuesday, September 8th. The shares were bought at an average price of $3.16 per share, for a total transaction of $101,120.00. Following the completion of the transaction, the insider owned 394,017 shares of the company’s stock, valued at approximately $1,245,093.72. This represents a 8.84% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 18.50% of the company’s stock.
Hedge Funds Weigh In On KORU Medical Systems
A number of institutional investors have recently added to or reduced their stakes in KRMD. BlackRock Inc. purchased a new position in shares of KORU Medical Systems during the second quarter worth about $11,039,000. Meros Investment Management LP bought a new position in shares of KORU Medical Systems in the second quarter worth approximately $3,190,589. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in KORU Medical Systems in the second quarter valued at approximately $642,000. Squarepoint Ops LLC raised its stake in KORU Medical Systems by 858.0% in the second quarter. Squarepoint Ops LLC now owns 124,755 shares of the company’s stock valued at $524,000 after purchasing an additional 111,733 shares in the last quarter. Finally, Royal Bank of Canada raised its stake in KORU Medical Systems by 77.3% in the first quarter. Royal Bank of Canada now owns 235,804 shares of the company’s stock valued at $1,019,000 after purchasing an additional 102,800 shares in the last quarter. 58.60% of the stock is currently owned by institutional investors.
KORU Medical Systems Company Profile
KORU Medical Systems, Inc (NASDAQ:KRMD) develops, manufactures and sells portable infusion systems for the administration of specialty pharmaceuticals and biologic therapies. Its products are designed to support ambulatory, home-based and other non-hospital infusion settings, giving patients and caregivers alternatives to traditional stationary infusion equipment.
The company’s product portfolio includes the FREEDOM Syringe Infusion System, including the FREEDOM60, FREEDOM35 and FREEDOMEDGE infusion pumps, along with related accessories and administration sets.
See Also
- Five stocks we like better than KORU Medical Systems
- Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?
- Brewing Trouble? Starbucks Spills the Beans on 250 Store Closures
- Stitch Fix Stock Plunges as Guidance Puts the Turnaround on Pause
- Harley-Davidson Insiders Are Buying: Is HOG Finally Turning Around?
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
